SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin?

(MedPage Today) -- Using SGLT2 inhibitors in the first-line treatment of type 2 diabetes lowered some cardiovascular risk, a claims database study showed. The combined 12-month risk for myocardial infarction (MI), stroke, and death was similar...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news